| EPN |
decreased @ 12, 36 ug/g |
brain weight, protein content, acetylcholinesterase and neurotoxic esterase versus controls |
Not Reported |
Hatchling |
12/group |
|
Toxicity Factor Datasets |
72 hr of incubation (time of treatment) |
Laboratory |
| EPN |
decreased @ 12 ug/g (82%); 36 ug/g (77%); 108 ug/g (70%) |
percent survival versus controls |
Not Reported |
Embryo |
10/group |
|
Toxicity Factor Datasets |
72 hr of incubation (time of treatment) |
Laboratory |
| EPN |
decreased @ 12, 36, 108 ug/g |
brain weight, acetylcholinesterase activity, neurotoxic esterase activity versus controls |
Not Reported |
Embryo |
10/group |
|
Toxicity Factor Datasets |
72 hr of incubation (time of treatment) |
Laboratory |
| EPN |
decreased @ 108 ug/g |
brain protein content versus controls |
Not Reported |
Embryo |
10/group |
|
Toxicity Factor Datasets |
72 hr of incubation (time of treatment) |
Laboratory |
| EPN |
decreased @ 36 (cholineserase only), 108 ug/g |
plasma alkaline phosphatase, aspartate aminotransferase, cholinesterase activities, and uric acid |
Not Reported |
Embryo |
12/group |
|
Toxicity Factor Datasets |
72 hr of incubation (time of treatment) |
Laboratory |
| EPN |
decreased @ 12, 36, 108 ug/g |
embryo weight and length, % normal survivors versus controls |
Not Reported |
Embryo |
12/group |
|
Toxicity Factor Datasets |
72 hr of incubation (time of treatment) |
Laboratory |
| EPN |
decreased @ 12 ug/g (48%), 36 ug/g (29%), 108 ug/g (0%) |
% surviving to hatch versus controls |
Not Reported |
Hatchling |
12/group |
|
Toxicity Factor Datasets |
72 hr of incubation (time of treatment) |
Laboratory |
| EPN |
decreased @ 12, 36 ug/g |
plasma cholinesterase activity, hemoglobin and uric acid content |
Not Reported |
Hatchling |
12/group |
|
Toxicity Factor Datasets |
72 hr of incubation (time of treatment) |
Laboratory |